Recap: Albireo Pharma Q2 Earnings



Albireo Pharma ALBO reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.


Albireo Pharma missed estimated earnings by 23.64%, reporting an EPS of $-2.04 versus an estimate of $-1.65.

Revenue was up $5.78 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.34 which was followed by a 18.37% drop in the share price the next day.

Here's a look at Albireo Pharma's past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -1.85 -1.35 -0.38 -1.96
EPS Actual -2.19 -0.57 -2.03 -1.90
Revenue Estimate 7.96M 12.48M 3.48M 1.98M
Revenue Actual 6.83M 32.52M 3.66M 2.43M

To track all earnings releases for Albireo Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: EarningsBZI-Recaps